Rise Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Rise Therapeutics's total funding is $0.4M.
Employee Data
- Rise Therapeutics has 17 Employees.
- Rise Therapeutics grew their employee count by 6% last year.
Rise Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder, President & CEO | Reveal Email/Phone |
2 | VP, Development and Manufacturing | Reveal Email/Phone |
3 | Clinical Scientist | Reveal Email/Phone |
Rise Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 13 | 0% | N/A | N/A |
#8 | $7.4M | 47 | 21% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Rise Therapeutics?
Rise Therapeutics is developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. The company develops unique, first-in-class immune modulatory drugs for the treatment of inflammation, autoimmunity and cancer.
keywords:N/A$0.4M
Total Funding
17
Number of Employees
N/A
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 17 | 6% | N/A |
#2 | $1.5M | 17 | -6% | N/A |
#3 | $4M | 17 | -6% | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $15M | 18 | 38% | N/A |